Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

Imielinski, Marcin, Berger, Alice H., Hammerman, Peter S., Hernandez, Bryan, Pugh, Trevor J., Hodis, Eran, Cho, Jeonghee, Suh, James, Capelletti, Marzia, Sivachenko, Andrey, Sougnez, Carrie, Auclair, Daniel, Lawrence, Michael S., Stojanov, Petar, Cibulskis, Kristian, Choi, Kyusam, de Waal, Luc, Sharifnia, Tanaz, Brooks, Angela, Greulich, Heidi, Banerji, Shantanu, Zander, Thomas, Seidel, Danila, Leenders, Frauke, Ansén, Sascha, Ludwig, Corinna, Engel-Riedel, Walburga, Stoelben, Erich, Wolf, Jürgen, Goparju, Chandra, Thompson, Kristin, Winckler, Wendy, Kwiatkowski, David, Johnson, Bruce E., Jänne, Pasi A., Miller, Vincent A., Pao, William, Travis, William D., Pass, Harvey I., Gabriel, Stacey B., Lander, Eric S., Thomas, Roman K., Garraway, Levi A., Getz, Gad, Meyerson, Matthew·2012·Cell
DOI 10.1016/j.cell.2012.08.029

Cited by (1,000)

Items 501–600 of 1,000

  1. Personalized therapy on the horizon for squamous cell carcinoma of the lung
    Han Sang Kim, Tetsuya Mitsudomi, Ross Andrew Soo, Byoung Chul Cho · 2013 · Lung Cancer
  2. Integrated molecular portrait of non-small cell lung cancers
    Vladimir Lazar, Chen Suo, Cédric Oréar, Joost van den Oord, Zsófia Balogh, Justine Guégan, Bastien Job, Guillaume Meurice, Hugues Ripoche, Stefano Calza et al. · 2013 · BMC Medical Genomics
  3. RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H
    Sirui Zhang, Yufang Bao, Xianfeng Shen, Yunjian Pan, Yue Sun, Man Xiao, Kexuan Chen, Huanhuan Wei, Ji Zuo, David Saffen et al. · 2020 · EBioMedicine
  4. Salt-Inducible Kinase 2 Regulates Mitotic Progression and Transcription in Prostate Cancer
    Hélène Bon, Karan Wadhwa, Alexander Schreiner, Michelle Osborne, Thomas D. Carroll, Antonio Ramos‐Montoya, Helen Ross‐Adams, Matthieu Visser, Ralf Hoffmann, Ahmed A. Ahmed et al. · 2014 · Molecular Cancer Research
  5. Classifying Ten Types of Major Cancers Based on Reverse Phase Protein Array Profiles
    Peiwei Zhang, Lei Chen, Tao Huang, Ning Zhang, Xiangyin Kong, Yu‐Dong Cai · 2015 · PLoS ONE
  6. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone
    Shaoxiong Chen, Karen Fritchie, Shi Wei, Naser M. Ali, Kendra L. Curless, Tiansheng Shen, Anna Teresa Brini, Farida Latif, Vaiyapuri P. Sumathi, Gene P. Siegal et al. · 2017 · Human Pathology
  7. Mutations in DNA repair genes are associated with increased neo-antigen load and activated T cell infiltration in lung adenocarcinoma
    Young Kwang Chae, Jonathan Forrest Anker, Preeti Bais, Sandeep Namburi, Francis Joseph Giles, Jeffrey H. Chuang · 2017 · Oncotarget
  8. A novel 3′ splice site recognition by the two zinc fingers in the U2AF small subunit
    Yoshida Hisashi, Park Sam-Yong, Oda Takashi, Akiyoshi Taeko, Sato Mamoru, Shirouzu Mikako, Tsuda Kengo, Kuwasako Kanako, Unzai Satoru, Muto Yutaka et al. · 2015 · Genes & Development
  9. Patterns and processes of somatic mutations in nine major cancers
    Peilin Jia, William J. Pao, Zhongming Zhao · 2014 · BMC Medical Genomics
  10. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer
    Mingjun Shi, Xiangyu Meng, Jacqueline Fontugne, Chun-Long Chen, François Radvanyi, Isabelle Bernard‐Pierrot · 2020 · Genome Medicine
  11. Chromatin Remodeling Induced by ARID1A Loss in Lung Cancer Promotes Glycolysis and Confers JQ1 Vulnerability
    Xiaoyu Liu, Zhi Li, Zhongmin Wang, Fei Liu, Linling Zhang, Jingjing Ke, Xu Xu, Yuefang Zhang, Yiting Yuan, Tao Wei et al. · 2022 · Cancer Research
  12. ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors
    Cristina Balbás-Martínez, Maria Socorro Rodriguez-Pinilla, Ariel Casanova, Orlando Domı́nguez, David G. Pisano, Gonzalo Goméz-López, Josep Lloreta, José A. Lorente, Núria Malats, Francisco X. Real · 2013 · PLoS ONE
  13. The clinical relevance of KRAS gene mutation in non-small-cell lung cancer
    József Tı́már · 2014 · Current Opinion in Oncology
  14. Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma
    De‐Chen Lin, Liang Xu, Ye Chen, Haiyan Yan, Masaharu Hazawa, Ngan Doan, JONATHAN W. SAID, Ling‐Wen Ding, Lizhen Liu, Henry He Yang et al. · 2015 · Cancer Research
  15. The spliceosome U2 snRNP factors promote genome stability through distinct mechanisms; transcription of repair factors and R-loop processing
    Michihiro Tanikawa, Kumar Sanjiv, Thomas Helleday, Patrick Herr, Oliver Mortusewicz · 2016 · Oncogenesis
  16. Chromatin Remodeling Factor BRG1 Regulates Stemness and Chemosensitivity of Glioma Initiating Cells
    Debolina Ganguly, Michelle M. Sims, Chun Cai, Meiyun Fan, Lawrence M. Pfeffer · 2018 · Stem Cells
  17. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms
    Gurudeeban Selvaraj, Satyavani Kaliamurthi, Aman Chandra Kaushik, Abbas Khan, Yong-Kai Wei, William Chi Shing Cho, Keren Gu, Dong‐Qing Wei · 2018 · Journal of Biomedical Informatics
  18. Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer.
    Peter Stephen Savas, Brett G.M. Hughes, Benjamin Solomon · 2013 · Europe PMC (PubMed Central)
  19. SMARCA4 mutations in KRAS ‐mutant lung adenocarcinoma: a multi‐cohort analysis
    Liang Liu, Tamjeed Ahmed, William Jeffrey Petty, Stefan C. Grant, Jimmy Ruiz, Thomas William Lycan, Ümit Topaloĝlu, Ping‐Chieh Chou, Lance David Miller, Gregory A. Hawkins et al. · 2020 · Molecular Oncology
  20. Genomic landscape of CD34 + hematopoietic cells in myelodysplastic syndrome and gene mutation profiles as prognostic markers
    Lan ping Xu, Zhaohui Gu, Yang Li, Jin-Li Zhang, Chunkang Chang, Chun‐Ming Pan, Jingyi Shi, Yang Shen, Bing Chen, Yueying Wang et al. · 2014 · Proceedings of the National Academy of Sciences
  21. The Hypoxic Tumor Microenvironment: Driving the Tumorigenesis of Non-Small-Cell Lung Cancer
    John Gordon Foster, Sybil C.K. Wong, Tyson V. Sharp · 2014 · Future Oncology
  22. MSEA: detection and quantification of mutation hotspots through mutation set enrichment analysis
    Peilin Jia, Quan Wang, Qingxia Chen, Katherine E. Hutchinson, William J. Pao, Zhongming Zhao · 2014 · Genome biology
  23. Genome analyses identify the genetic modification of lung cancer subtypes
    Yong Zhang, Diane C. Wang, Lin Shi, Bijun Zhu, Zhihui Min, Jianjun Jin · 2016 · Seminars in Cancer Biology
  24. Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay
    Yue Sun, Yufang Bao, Wenjian Han, Fan Song, Xianfeng Shen, Jiawei Zhao, Ji Zuo, David W. Saffen, Wei Chen, Zefeng Wang et al. · 2017 · Nucleic Acids Research
  25. Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role
    Shao-Ming Shen, Yan Ji, Cheng Zhang, Shuang-Shu Dong, Shuo Yang, Zhong Xiong, Meng-Kai Ge, Yun Yu, Xia Li, Meng Guo et al. · 2018 · Nature Communications
  26. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis
    Mengyu Zhang, Xiaoxia Liu, Hao Li, Rui Li, Xiao Liu, Yi-Qing Qu · 2018 · International Journal of Medical Sciences
  27. Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer
    Jessica A. Hellyer, Henning Stehr, Millie Snigdha Das, Sukhmani Kaur Padda, Kavitha J. Ramchandran, Joel W. Neal, Maximilian Diehn, Heather A. Wakelee · 2019 · Lung Cancer
  28. Metabolic features of cancer cells in NRF2 addiction status
    Okazaki, Keito, Papagiannakopoulos, Thales, Motohashi, Hozumi · 2020 · Biophysical Reviews
  29. Genes and Pathology of Non-Small Cell Lung Carcinoma
    Shingo Sakashita, Mai Sakashita, Ming‐Sound Tsao · 2013 · Seminars in Oncology
  30. The RNA-binding landscape of RBM10 and its role in alternative splicing regulation in models of mouse early development
    Julie Rodor, David R FitzPatrick, Eduardo Eyras, Javier F. Cáceres · 2016 · RNA Biology
  31. RBM10: Structure, functions, and associated diseases
    Akira Inoue · 2021 · Gene
  32. Discoidin Domain Receptor 2 Signaling Networks and Therapy in Lung Cancer
    Leo S. Payne, Paul H. Huang · 2014 · Journal of Thoracic Oncology
  33. Chromothripsis-like chromosomal rearrangements induced by ionizing radiation using proton microbeam irradiation system
    Maki Morishita, Tomoki Muramatsu, Yumiko Suto, Momoki Hirai, Teruaki Konishi, Shin Hayashi, Daichi Shigemizu, Tatsuhiko Tsunoda, Keiji Moriyama, Johji Inazawa · 2016 · Oncotarget
  34. Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1
    Qian Zhang, Haibo Yan, Jie Wang, Shu‐Jian Cui, Xiaoqing Wang, Ying-Hua Jiang, Feng Li, Pengyuan Yang, Feng Liu · 2016 · Oncotarget
  35. Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma
    Melissa Gilbert‐Ross, Jessica Marie Konen, Junghui Koo, John A. Shupe, Brian Scott Robinson, Walter Guy Wiles, Chunzi Huang, W. David Martin, Madhusmita Behera, Geoffrey Hughes Smith et al. · 2017 · JCI Insight
  36. Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies
    Zhong‐Yi Dong, Chao Zhang, Yufa Li, Jian Su, Zhi Xie, Si‐Yang Maggie Liu, Li‐Xu Yan, Zhihong Chen, Xue‐Ning Yang, Jun‐Tao Lin et al. · 2017 · Journal of Thoracic Oncology
  37. Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
    Marcel Wiesweg, Stefan Kasper, Karl Worm, Thomas Herold, Henning Reis, Linda Sara, Martin Metzenmacher, Annalena Abendroth, Kaid Darwiche, Clemens Aigner et al. · 2018 · Oncogene
  38. STAG Mutations in Cancer
    Laura Romero‐Pérez, Didier Surdez, Erika Brunet, Olivier Delattre, Thomas G. P. Grünewald · 2019 · Trends in cancer
  39. Identification of relevant genetic alterations in cancer using topological data analysis
    Raúl Rabadán, Yamina Mohamedi, Udi Rubin, Tim Chu, Adam N. Alghalith, Oliver Elliott, Luís Arnes, Santiago Cal, Álvaro J. Obaya, Arnold J. Levine et al. · 2020 · Nature Communications
  40. Downregulation of SAMHD1 Expression Correlates with Promoter DNA Methylation in Sézary Syndrome Patients
    Suresh de Silva, Feifei Wang, Timothy S. Hake, Pierluigi Porcu, Henry K. Wong, Li Juan Wu · 2013 · Journal of Investigative Dermatology
  41. New therapeutic perspectives in CCDC 6 deficient lung cancer cells
    Francesco Morra, Chiara Luise, Roberta Visconti, Stefania Staibano, Francesco Merolla, Gennaro Ilardi, Gianluca Guggino, Simona Paladino, Daniela Sarnataro, Renato Franco et al. · 2014 · International Journal of Cancer
  42. Mechanisms of Base Substitution Mutagenesis in Cancer Genomes
    Albino Bacolla, D.N. Cooper, Karen M. Vásquez · 2014 · Genes
  43. Mutant HRAS as novel target for MEK and mTOR inhibitors
    M. Kiessling, Alessandra Curioni-Fontecedro, P. Samaras, K. Atrott, J. Cosin-Roger, S. Lang, M. Scharl, G. Rogler · 2015 · OncoTarget
  44. Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale
    Louise J. Barber, Matthew N. Davies, Marco Gerlinger · 2014 · Current Opinion in Genetics & Development
  45. Molecular diagnostics of lung cancer in the clinic
    Lynette Marie Sholl · 2017 · Translational Lung Cancer Research
  46. Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients
    Subasri Armon, Paul M Hofman, Marius Ilié · 2021 · Cells
  47. The Role of Smoking Status on the Progression-Free Survival of Non-Small Cell Lung Cancer Patients Harboring Activating Epidermal Growth Factor Receptor (EGFR) Mutations Receiving First-Line EGFR Tyrosine Kinase Inhibitor Versus Platinum Doublet Chemotherapy: A Meta-Analysis of Prospective Randomized Trials
    Yoshikazu Hasegawa, Masahiko Ando, Makoto Maemondo, Satomi Yamamoto, Shun‐ichi Isa, Hideo Saka, Akihito Kubo, Tomoya Kawaguchi, Minoru Takada, Rafael Rosell et al. · 2015 · The Oncologist
  48. The evolving epigenome
    Dieter Weichenhan, Christoph Plass · 2013 · Human Molecular Genetics
  49. Requirement for BUB1B/BUBR1 in tumor progression of lung adenocarcinoma
    Honglin Chen, James Lee, Noelyn M. Kljavin, Benjamin Haley, Anneleen Daemen, Leisa Johnson, Yuxin Liang · 2015 · Genes & Cancer
  50. Re-Evaluating Clonal Dominance in Cancer Evolution
    Rebecca A. Burrell, Charles Swanton · 2016 · Trends in cancer
  51. Splicing Factor Mutations in Cancer
    Rafael L. Bejar · 2016 · Advances in experimental medicine and biology
  52. Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers
    Yenkai Lim, Yunxia Wan, Dimitrios Vagenas, Dmitry A. Ovchinnikov, Chris Perry, Melissa J. Davis, Chamindie Punyadeera · 2016 · BMC Cancer
  53. *K-means and cluster models for cancer signatures
    Zura Kakushadze, Willie Yu · 2017 · Biomolecular Detection and Quantification
  54. Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma
    Rintaro Hashizume · 2017 · Neurologia medico-chirurgica
  55. Matched Whole-Genome Sequencing (WGS) and Whole-Exome Sequencing (WES) of Tumor Tissue with Circulating Tumor DNA (ctDNA) Analysis: Complementary Modalities in Clinical Practice
    Robin John Lester Imperial, Marjan Nazer, Zaheer Ahmed, Audrey E. Kam, Timothy Pluard, Waled Bahaj, Mia Alyce Levy, Timothy Michael Kuzel, Dana Michelle Hayden, Sam G. Pappas et al. · 2019 · Cancers
  56. Cancer associated fibroblast: Mediators of tumorigenesis
    Jennifer I. Alexander, Edna Cukierman · 2020 · Matrix Biology
  57. FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC
    Francesco Morra, Chiara Luise, Francesco Merolla, Ina Poser, Roberta Visconti, Gennaro Ilardi, Simona Paladino, Hiroyuki Inuzuka, Gianluca Guggino, Roberto Monaco et al. · 2015 · Oncotarget
  58. Selective targeting of KRAS oncogenic alleles by CRISPR/Cas9 inhibits proliferation of cancer cells
    Lee, Wookjae, Lee, Joon Ho, Jun, Soyeong, Lee, Ji Hyun, Bang, Duhee · 2018 · Scientific Reports
  59. Chromatin structure in double strand break repair
    Anastas G. Gospodinov, Zdenko Herceg · 2013 · DNA repair
  60. Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma
    Yuqing Lou, Rong Li, Jielin Liu, Yanwei Zhang, Xueyan Zhang, Bo Jin, Ya Liu, Zuoguang Wang, Hua Zhong, Shaojun Wen et al. · 2015 · Medical Oncology
  61. Molecular Diversity and Associated Phenotypic Spectrum of GermlineCBLMutations
    Simone Martinelli, Emilia Stellacci, Luca Pannone, Daniela D’Agostino, Federica Consoli, Christina Lißewski, Marianna Silvano, Giulia Cencelli, Francesca Romana Lepri, Silvia Beatrice Maitz et al. · 2015 · Human Mutation
  62. Rapid Induction of Lung Adenocarcinoma by Fibroblast Growth Factor 9 Signaling through FGF Receptor 3
    Yongjun Yin, Tomoko Betsuyaku, Joel Richard Garbow, Jinbai Miao, Ramaswamy Govindan, David M. Ornitz · 2013 · Cancer Research
  63. A Splicing-Independent Function of RBM10 Controls Specific 3′ UTR Processing to Regulate Cardiac Hypertrophy
    Nimmy Mohan, Vikas Kumar, Divya T. Kandala, C. Sudha Kartha, Rakesh S. Laishram · 2018 · Cell Reports
  64. Redox inhibition of protein phosphatase PP2A: Potential implications in oncogenesis and its progression
    Deepika Raman, Shazib Pervaiz · 2019 · Redox Biology
  65. Salt-Inducible Kinase 2: An Oncogenic Signal Transmitter and Potential Target for Cancer Therapy
    Fangyu Chen, Liuwei Chen, Qin Qin, Xinchen Sun · 2019 · Frontiers in Oncology
  66. The mutational landscape of human somatic and germline cells
    Luiza Moore, Alex Cagan, Tim H. H. Coorens, Matthew D. C. Neville, Rashesh Sanghvi, Mathijs Arnoud Sanders, Thomas R. W. Oliver, Daniel A. Leongamornlert, Peter Ellis, Ayesha Noorani et al. · 2022 · Yearbook of pediatric endocrinology
  67. Role of somatic cancer mutations in human protein lysine methyltransferases
    Srikanth Kudithipudi, Albert Jeltsch · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  68. Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients
    Stephen Q. Wong, ANDREW P. FELLOWES, K. McK. Doig, Jason Ellul, Trent J. Bosma, Debra E. Irwin, Ravikiran Vedururu, Angela Tan, Jonathan M. Weiss, Kian Sing Chan et al. · 2015 · British Journal of Cancer
  69. Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines
    Valentina Fustaino, Dario Presutti, Teresa Colombo, Beatrice Cardinali, Giuliana Papoff, Rossella Brandi, Paola Bertolazzi, Giovanni Felici, Giovina Ruberti · 2017 · Oncotarget
  70. Long-read sequencing for non-small-cell lung cancer genomes
    Yoshitaka Sakamoto, Liu Xu, Masahide Seki, Toshiyuki Yokoyama, Masahiro Kasahara, Yukie Kashima, Akihiro Ohashi, Yoko Shimada, Noriko Motoi, Katsuya Tsuchihara et al. · 2020 · Genome Research
  71. Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies
    Yi-Long Lung Cancer Wu, Egbert Frederik Smit, Todd Michael Bauer · 2021 · Cancer Treatment Reviews
  72. NRMT2 is an N-terminal monomethylase that primes for its homologue NRMT1
    Janusz Jurand Petkowski, Lindsay A. Bonsignore, John G. Tooley, Daniel Wade Wilkey, Michael L. Merchant, Ian G. Macara, Christine E. Schaner Tooley · 2013 · Biochemical Journal
  73. DNA Methylation at the Novel CpG Sites in the Promoter of MED15 / PCQAP Gene as a Biomarker for Head and Neck Cancers
    Dmitry A. Ovchinnikov, Yunxia Wan, William B. Coman, Pratibala Pandit, Justin John Cooper-White, James Gordon Herman, Chamindie Punyadeera · 2014 · Biomarker Insights
  74. Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung
    Seung‐Hyun Jung, Min Sung Kim, Sung Hak Lee, Hyun-Chun Park, Hyun Joo Choi, Lee-So Maeng, Ki Ouk Min, Jeana Kim, Tae In Park, Ok Ran Shin et al. · 2016 · Proceedings of the National Academy of Sciences
  75. SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines
    Katharina Ehrenhöfer-Wölfer, Teresa Puchner, Cornelia Schwarz, Janine Rippka, Silvia Blaha-Ostermann, Ursula Strobl, Alexandra Hörmann, Gerd Bader, Stefan Kornigg, Stephan K. Zahn et al. · 2019 · Scientific Reports
  76. Functional significance of U2AF1 S34F mutations in lung adenocarcinomas
    Mohammad Shahrokh Esfahani, Luke J. Lee, Young-Jun Jeon, Ryan A. Flynn, Henning Stehr, Angela Bik‐Yu Hui, Noriko Ishisoko, Eric Kildebeck, Aaron M. Newman, Scott Victor Bratman et al. · 2019 · Nature Communications
  77. Genomics of adult and pediatric solid tumors.
    Zahraa Rahal, Farah Abdulhai, Humam N. Kadara, Raya Hamad Saab · 2018 · Europe PMC (PubMed Central)
  78. E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non–small cell lung cancer
    Ke Li, Xufen Zheng, Hua Tang, Yuan‐Sheng Zang, Chunling Zeng, Xiaoxiao Liu, Yanying Shen, Yuzhi Pang, Simin Wang, Feifei Xie et al. · 2021 · The Journal of Experimental Medicine
  79. PrimPol—A new polymerase on the block
    Sean G. Rudd, Julie Bianchi, Aidan J. Doherty · 2014 · Molecular & Cellular Oncology
  80. Large cell carcinoma of the lung: A tumor in search of an author. A clinically oriented critical reappraisal
    Giuseppe Pelosi, Mattia Barbareschi, Alberto Cavazza, Paolo Graziano, Giulio Rossi, Mauro Giulio Papotti · 2015 · Lung Cancer
  81. Unraveling Tumor Grading and Genomic Landscape in Lung Neuroendocrine Tumors
    Giuseppe Pelosi, Mauro Giulio Papotti, Guido Rindi, Aldo Scarpa · 2014 · Endocrine Pathology
  82. DNA Replication Error-Induced Extinction of Diploid Yeast
    Alan J. Herr, Scott R. Kennedy, Gary M. Knowels, Eric M Schultz, Bradley D. Preston · 2014 · Genetics
  83. Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma
    Chanida Vinayanuwattikun, Florence Le Calvez‐Kelm, Behnoush Abedi‐Ardekani, David Georgievich Zaridze, Anush Mukeria, Catherine Voegele, Maxime Vallée, Dewajani Purnomosari, Nathalie Forey, Geoffroy Durand et al. · 2016 · Scientific Reports
  84. A Non-Active-Site SET Domain Surface Crucial for the Interaction of MLL1 and the RbBP5/Ash2L Heterodimer within MLL Family Core Complexes
    Stephen A. Shinsky, Michael Hu, Valarie E. Vought, Sarah Boon Hsi Ng, Michael J. Bamshad, Jay Shendure, Michael S. Cosgrove · 2014 · Journal of Molecular Biology
  85. Cancer genomics identifies disrupted epigenetic genes
    Laia Simó‐Riudalbas, Manel Esteller · 2013 · Human Genetics
  86. Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine
    Simona Coco, Anna Truini, Irene Vanni, Maria Giovanna Dal Bello, Angela Alama, Erika Rijavec, Carlo Genova, Giulia Barletta, Claudio Sini, Giovanni Burrafato et al. · 2014 · Current Drug Targets
  87. Genomic Characterization of Non–Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing
    Luiz Henrique Araujo, Cynthia Dawn Timmers, Erica Hlavin Bell, Konstantin Shilo, Philip Edward Lammers, Weiqiang Zhao, Thanemozhi G. Natarajan, Clinton J. Miller, Jianying Zhang, Ayse Selen Yilmaz et al. · 2015 · Journal of Clinical Oncology
  88. Predictive biomarkers in precision medicine and drug development against lung cancer
    Bingliang Fang, Reza John Mehran, John Victor Heymach, Stephen G. Swisher · 2015 · 癌症：英文版
  89. A new generation of cancer genome diagnostics for routine clinical use: overcoming the roadblocks to personalized cancer medicine
    Johannes M. Heuckmann, Roman Kurt Thomas · 2015 · Annals of Oncology
  90. Alternative splicing and cancer metastasis: prognostic and therapeutic applications
    Diego M. Marzese, Ayla O. Manughian-Peter, Javier I. J. Orozco, Dave S.�B. Hoon · 2018 · Clinical & Experimental Metastasis
  91. RBM10 Regulates Tumor Apoptosis, Proliferation, and Metastasis
    Yingshu Cao, Xin Di, Qinghua Zhang, Ranwei Li, Ke Wang · 2021 · Frontiers in Oncology
  92. Autophagy regulation by RNA alternative splicing and implications in human diseases
    Patricia González-Rodríguez, Daniel J. Klionsky, Bertrand Joseph · 2022 · Nature Communications
  93. mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo‐alveolar adenoma and adenocarcinoma after multi‐walled carbon nanotube inhalation exposure in mice
    Brandi N. Snyder‐Talkington, Chunlin Dong, Linda M. Sargent, Dale W. Porter, Lauren M. Staska, Ann F. Hubbs, Rebecca A. Raese, Walter McKinney, Bean T. Chen, Lori A. Battelli et al. · 2015 · Journal of Applied Toxicology
  94. Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma
    Shaogang Lv, Jian Xue, Chuanyong Wu, Lin Wang, Jing Wu, Shujun Xu, Xiaohui Liang, Jiatao Lou · 2016 · Journal of Cancer
  95. Construction of a specific SVM classifier and identification of molecular markers for lung adenocarcinoma based on lncRNA-miRNA-mRNA network
    Jingming Zhao, Wei Cheng, Xigang He, Yanli Liu, Ji Li, Jiaxing Sun, Jinfeng Li, Fangfang Wang, Yufang Gao · 2018 · OncoTargets and Therapy
  96. Elucidation of the aberrant 3′ splice site selection by cancer-associated mutations on the U2AF1
    Hisashi Yoshida, Sam‐Yong Park, Gyosuke Sakashita, Yuko Nariai, Kanako Kuwasako, Y. Muto, Takeshi Urano, Eiji OBAYASHI · 2020 · Nature Communications
  97. Exosomal microRNA‐26b‐5p down‐regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells
    Han, Fushi, Huang, Dongdong, Huang, Xinghong, Wang, Wei, Yang, Shusong, Chen, Shuzhen · 2020 · Journal of Cellular and Molecular Medicine
  98. Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review
    Emma Karlsen, Sam L. Kahler, Joan Tefay, Shannon R. Joseph, Fiona Simpson · 2021 · Cells
  99. Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors
    Sarah M. Haeger, Joshua J. Thompson, Sean Kalra, Timothy G. Cleaver, Daniel T. Merrick, X‐J Wang, Stephen P. Malkoski · 2015 · Oncogene
  100. Silent Mutations Make Some Noise
    Siyuan Zheng, Hoon Kim, Roel G.W. Verhaak · 2014 · Cell